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GOSNELL, B. A. AND D. D. KRAHN. The effects of continuous naltrexone infusions on diet preferences are modulated by 
adaptation to the diets. PHYSIOL BEHAV 51(2) 239-244, 1992.--Two groups of male rats were placed on a feeding regimen in 
which a fat/protein diet and a carbohydrate/protein diet were available ad lib. Naltrexone was infused via osmotic minipumps 
either at the time the diets were introduced or after one week of adaptation to the diets. In rats adapted to the diets, naltrexone 
caused a decrease in the intakes of fat/protein and carbohydrate/protein diets. Relative preferences for the two diets were generally 
unchanged. In contrast, when naltrexone was infused at the time of introduction of the diets, a polarization phenomenon was 
observed: rats tended to consume nearly all of their daily calories from either one diet or the other. Six rats (out of 10) showed a 
stronger preference for the carbohydrate/protein diet than did any of the saline-treated rats, while 3 showed a stronger preference 
for the fat/protein diet than did any of the saline-treated rats. Thus, the effect was not diet- or macronutrient-specific. These 
preferences became significantly less extreme after termination of naltrexone infusions. Conditioned aversions and naltrexone- 
induced reductions in exploratory behavior are discussed as potential explanations for this polarization effect. These results indi- 
cate that naltrexone has differential effects on the development versus the maintenance of diet preferences. Further, they emphasize 
the importance of examining individual differences as well as baseline preferences in studies on the control of intake and diet 
selection. 
Naltrexone Opioids Food intake Diet selection Feeding Fat Carbohydrate Macronutrient 
FOOD intake, diet selection and/or taste preferences have been 
shown to be influenced by the administration of opioid agonists 
and antagonists. A currently favored hypothesis is that opioids 
play a role in mediating the pleasurable or rewarding aspects of 
food (9,39). Naloxone reduces the intake of palatable foods and 
fluids, whereas opioid agonists cause increases in intake (6, 8, 
17, 18, 21, 26, 27). It has also been reported that in self-selec- 
tion experiments, opioid agonists and naloxone cause preferen- 
tial changes in the intake of fat, particularly when rats are food- 
restricted (31, 33, 38, 41, 42). We have recently reported, 
however, that baseline preferences for the test diets are impor- 
tant determinants of the effect of morphine on intake (16). There 
were marked differences between rats in their baseline daily in- 
takes of a fat/protein diet vs. a carbohydrate/protein diet. In rats 
with a baseline preference for the fat diet, morphine primarily 
stimulated fat intake. In carbohydrate-preferring rats, however, 
morphine primarily stimulated intake of the carbohydrate diet. 
Thus, the effect of morphine appeared to be preference-specific 
rather than macronutrient-specific. Similarly, Evans and Vaccar- 
ino (12) found that morphine stimulated intake of a protein-rich 
diet in protein-deprived rats, and slightly increased intake of a 
carbohydrate-rich diet in carbohydrate-deprived rats. 
Most studies of the type described above were performed 
with rats previously adapted to the test diets, i.e., after rats have 
learned about both the pre- and postabsorptive consequences of 
the initially novel diets. There is some evidence that opioids may 
be involved in the acquisition of taste preferences. Leshem (23) 
found that after repeated pairings of morphine injections with ei- 
ther sucrose or quinine solutions, the preference for sucrose in- 
creased, whereas the aversion to quinine was enhanced. Lynch 
(27) reported that daily treatment with naloxone blocked the ac- 
quisition of saccharin preferences. Conversely, treatment with 
the kappa agonist U-50,488H consistently facilitated the intake 
of 20% sucrose (28). In the experiment reported here, we exam- 
ined the effect of opioid receptor blockade in rats with no previ- 
ous experience with dietary self-selection of specially formulated 
test diets. This effect was compared to that obtained with rats 
allowed to adapt to the diets prior to receptor blockade. 
METHOD 
Twenty male Sprague-Dawley rats (Charles River, Wilming- 
ton, MA) were individually housed in stainless steel cages in a 
room in which the lights were on from 7 a.m. to 7 p.m. They 
were maintained on standard lab chow (Purina No. 5001) from 
the time of arrival into the lab until the beginning of the experi- 
ment. Five days after arrival, each rat was anesthetized with 
ether and an osmotic minipump was implanted subcutaneously 
in the interscapular region (Alzet pump model No. 2001, Alza 
Corp., Palo Alto, CA). These minipumps, with a nominal flow 
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TABLE I 
COMPOSITION OF DIETS 
Diet 
Carbohydrate/Protein Fat/Proteil~ 
Corn Starch 919.4 -- 
Dextrin 459.6 -- 
Sucrose 153.2 -- 
*Casein 429.8 429.8 
DL-Methionine 6.4 6.4 
Vegetable Shortening -- 647.0 
Safflower Oil -- 34.0 
tAIN-76A Vitamin Mix 20.0 20.0 
rAIN-76 Mineral Mix 70.0 70.0 
Choline Chloride 4.0 4.0 
Cellulose (Alphacel) 100.0 100.0 
Weight (g) 2162.4 13 l 1.2 
~tTotal Energy (kcal) 7812.9 7813.1 
Energy Density (kcal/g) 3.61 5.96 
All components are expressed as weight (grams). 
*Assuming a protein content of 90%. 
+The vitamin and mineral mixes contain 97 and 12% sucrose, respec- 
tively. 
SBased on energy values of 4, 9 and 4 kcal/g for carbohydrate, fat 
and protein. 
rate of 1 wl/h and capacity of 200 Ixl, contained either 0.9% 
saline (n=  10) or naitrexone hydrochloride (65 mg/ml) (n= 10) 
filtered through a 22 t~m 2 syringe filter. Naltrexone was pur- 
chased from Sigma Chemical Co. (St. Louis, MO). Rats that 
received naltrexone weighed 308_  2 g at the time of surgery. 
Thus, naltrexone was delivered at an average initial dose of 211 
ixg/kg/h. Pumps were filled the day before implantation and 
primed by placing them overnight in physiological saline at room 
temperature. Food was withdrawn at the time of surgery; later 
the same day (approximately 4-7 h after surgery), two separate 
diets were placed into each cage: a carbohydrate/protein diet 
(CP) and a fat/protein diet (FP). On a caloric basis, both diets 
contained equivalent amounts of protein (20%), vitamins, min- 
erals, choline and fiber (see Table 1). All components of the 
diets were purchased from ICN Biochemicals (Cleveland, OH), 
with the exception of DL-methionine (Sigma Chemical Co., St. 
Louis, MO), choline chloride (Mallinckrodt, Paris, KY) and 
vegetable shortening (Crisco, purchased locally). The two diets 
were available ad lib, and intakes were measured every day at 
approximately the same time (10 a.m. to noon). Positions of the 
two diet jars in the cages were reversed daily. Body weights 
were also measured daily. Seven days later, rats were again 
anesthetized with ether, and the minipumps were replaced. Rats 
that initially were given saline-filled pumps were given pumps 
containing naltrexone (75 mg/ml), and rats that initially had nal- 
trexone-filled pumps were given pumps containing saline. One 
rat died during this procedure. Data from this rat were deleted 
in all analyses involving comparisons over time. At the time of 
implantation, rats receiving naltrexone weighed 353 -+ 
7 g. Thus, the average initial dose was 212 ixl/kg/h. As before, 
the CP and FP diets were returned approximately 4-7 h after 
surgery, and ad lib intakes and body weights were measured 
daily. Seven days after this second pump implantation, all pumps 
were removed (under ether anesthesia), and intakes and body 
weight measures continued for 7 more days. 
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FIG. 1. Diet preferences of rats treated with either saline or naltrexone 
(n = 10/group). Preferences are based on the number of calories con- 
sumed from the fat/protein diet during treatment days 6 and 7, expressed 
as a percentage of total caloric intake. Scores indicate deviations from 
an equal preference for the two diets (50%-50%): positive values indi- 
cate a relative preference for the fat/protein diet, and negative values 
indicate a relative preference for the carbohydrate/protein diet. Rats were 
rank-ordered within each group for purposes of illustration. *One rat's 
deviation score was zero, which indicates an equal preference for the 
two diets. 
To determine the effect of naltrexone on food intake in rats 
adapted to the diets (Saline-NTX-Ctl group), the intakes on the 
final 2 days of the saline infusion period were averaged. Intakes 
of each diet on subsequent days were compared to these base- 
line values with Dunnett's test (two-tailed). Body weights and 
preference scores were analyzed with a two-factor analysis of 
variance (ANOVA: group × treatment period). Comparisons 
between groups were tested with t-tests; comparisons within a 
group (repeated measures) were tested with Bonferroni or Dun- 
nett tests (all two-tailed). For all comparisons, the error terms 
were based only on the two groups being compared. 
RESULTS 
It was noted early in the experiment that rats given naltrex- 
one at the time the two diets were introduced appeared to be at 
the extremes in terms of diet preferences. Such extremes were 
not noted in the saline-treated rats. To illustrate this, preference 
for the fat/protein diet was computed for each rat by expressing 
intake of this diet (in kcal) over the final two days of the infu- 
sion period as a percentage of total caloric intake for this pe- 
riod. These percentages were then converted into deviation scores 
by subtracting 50%. Thus, a deviation score of 50% indicated 
an exclusive consumption of the fat/protein diet, whereas a de- 
viation score of - 5 0 %  indicated exclusive consumption of the 
carbohydrate/protein diet. For purposes of illustration in Fig. 1, 
rats in each group were rank-ordered from low to high. It is clear 
that naltrexone-treated rats were more extreme in their diet 
choices: six rats showed a stronger preference for the carbohy- 
drate/protein diet than did any of the saline-treated rats, while 3 
showed a stronger preference for the fat/protein diet than did any 
of the saline-treated rats. 
Naltrexone clearly caused a reduction in total caloric intake. 
This effect dissipated over days, however, such that intake on 
the final days was approximately normal. To determine the ef- 
fects of naltrexone on diet selection, only data from the saline- 
naltrexone-control group were considered. In addition, data from 
one rat were deleted from this analysis only, as this rat differed 
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FIG. 2. Daily intakes of the fat/protein and carbohydrate/protein diets 
(mean---s.e.m.) in rats receiving infusions of saline during week 1, nal- 
trexone during week 2 and no infusions during week 3 (n = 9). Asterisks 
indicate significant differences in mean intake when compared to aver- 
age mean intakes for days 6 and 7 of week 1 (Dunnett's test, two-tailed, 
p<0.05). 
from all others in the group by developing an extreme prefer- 
ence for the carbohydrate diet. Data from this rat were included 
in considerations of variability in diet preferences, total intake 
and body weight (Figs. 1, 3 and 4). As discussed above, rats 
receiving naltrexone at the time the diets were introduced devel- 
oped extreme diet preferences which precluded conventional be- 
tween-group comparisons. Compared to mean intakes on the two 
days immediately before drug infusions began, naltrexone caused 
a reduction in total daily intake for each of the 7 infusion days 
(Dunnett t-tests, 2-tailed) (Fig. 2). Following the termination of 
naltrexone infusions, intake increased and was significantly greater 
than baseline on day 3 of the postnaltrexone (control) phase. In- 
take of the carbohydrate/protein diet was significantly decreased 
on days 1-4 and 6-7 of the naltrexone infusion period. Follow- 
ing removal of the naltrexone pumps, intake of this diet re- 
mained significantly below baseline. Intake of the fat/protein diet 
was decreased only for days 1 and 2 of the infusion period, af- 
ter which it gradually returned to control levels. After the termi- 
nation of naltrexone infusions, fat/protein intake increased above 
baseline and was significantly elevated on days 2, 3 and 6 of 
this period. Preference for the fat diet (calculated as dally calo- 
ries consumed from this diet expressed as a percentage of total 
caloric intake) did not significantly differ from baseline during 
naltrexone infusion. There was, however, a tendency for this 
percentage to increase during the course of the infusion period 
(from 53-+ 8% on day 1 of naltrexone infusions to 64___ 6% on 
day 7). Following termination of drug infusions, fat preference 
increased and was significantly greater than baseline fat prefer- 
ence on days 3-7. 
With such widely varying diet preferences in rats receiving 
naltrexone at the beginning of the experiment, presentation of 
mean preferences would be misleading, as the extreme fat-pre- 
ferring animals tend to balance the extreme carbohydrate-prefer- 
ring animals, yielding a mean preference for the fat diet of 
43 + 15% (mean - s.e.m., n = 9) for the last two days of the first 
treatment week (vs. 53 --- 6% fat diet preference for saline-treated 
rats, n = 10). To compare statistically the "extremism of prefer- 
ence" of the naltrexone- vs. saline-treated animals, the absolute 
value of the deviation scores described above were used. The 
means of the absolute deviations for each group were compared 
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FIG. 3. Absolute deviations (mean_s.e.m) from equal preference for 
the two diets. Rats represented by the open circles received saline and 
naltrexone infusions during weeks 1 and 2, respectively (n= 10). Rats 
represented by the closed circles received naltrexone and saline infusions 
during weeks 1 and 2, respectively (n = 9) (on days 1 and 2 of week 1, 
one rat consumed no food; n = 8 on these days). There were no infu- 
sions during the third week (control). Asterisks indicate significant dif- 
ferences between the groups (*p<0.05, two-tailed t-tests). 
with t-tests on each day of the experiment. As shown in Fig. 3, 
rats treated with naltrexone at the beginning were more extreme 
in their diet choices on each day during infusion. These devia- 
tions declined during saline infusions in the following week to a 
level similar to that observed in the other group. An analysis of 
variance (group × treatment week) was used to verify statisti- 
cally the apparent changes in extremism which occurred over 
time. In this analysis, an absolute deviation score was based on 
intakes on the final two days of each week of treatment. The 
group and week main effects were not significant, F(1,17)= 2.55 
and F(2,34)= 1.68, respectively, p>0.05.  There was, however, 
a significant interaction, F(2,34)= 10.82, p<0.001.  Post hoc 
tests confirmed that in week 1, naltrexone-treated rats were more 
"ext reme"  than saline-treated rats. In contrast, when saline- 
treated rats were given naltrexone in week 2, extremism scores 
did not increase significantly, nor did they change after naltrex- 
one was withdrawn in week 3. Rats treated with naltrexone in 
week 1 became significantly less extreme when naltrexone was 
withdrawn (weeks 2 and 3). 
Body weights generally showed the same pattern of changes 
as that observed with total daily intakes. In both groups of rats, 
body weights decreased when measured one day after the begin- 
ning of naltrexone infusions ( - 8 - - 2  g and - 2 2 - 3  g for the 
Saline-NTX-Control and NTX-Saline-Control groups, respective- 
ly). These decreases cannot be attributed to the pump implanta- 
tion (or removal) procedure alone, as there were either increases 
(or smaller decreases) in body weight when saline-filled pumps 
were implanted, as well as when all pumps were removed. An 
inspection of Fig. 4 indicates that body weight increased at a 
fairly constant rate within each treatment week. To compare 
rates of weight gain across groups and treatment periods, daily 
changes in body weight were averaged for each rat across the 
final 6 days of each treatment period. Changes following day 1 
were omitted to eliminate the potential effects of surgery on 
weight gain. These rates were analyzed with a two-factor ANOVA 
(group × treatment week). The group and week effects were 
not s ignif icant ,  F ( 1 , 1 7 ) = 2 . 4 5 ,  p > 0 . 0 5 ;  F ( 2 , 3 4 ) = 3 . 0 6 ,  
0 .05<p<0.10.  There was, however, a significant group x week 
interaction, F(2,34)=18.81,  p<0.001.  In the group receiving 
naltrexone after adaptation to the diets (Sal-NTX-Ctl), naltrex- 
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FIG. 4. Upper panel: Total dally caloric intakes (mean+s.e.m). Rats 
represented by the open circles received saline and naltrexone infusions 
during weeks 1 and 2, respectively (n= 10). Rats represented by the 
closed circles received naltrexone and saline infusions during weeks 1 
and 2, respectively (n= 9). There were no infusions during the third 
week (control). Asterisks indicate a significant difference in intake for 
the saline-NTX-control group compared to intakes of this group on days 
6 and 7 of week 1 (Dunnett's tests, two-tailed). Lower panel: Body 
weights (mean-s.e.m.) for rats receiving infusions of saline and nal- 
trexone. 
one significantly slowed the rate of body weight gain from 
8.1---0.6 g/day to 4.1---0.4 g/day. Following naltrexone re- 
moval, this rate significantly increased to prenaltrexone levels 
(7.4+_0.6 g/day). In contrast, rats receiving naltrexone in week 
1 gained weight at a rate similar to that of saline-treated rats 
(6.6__-0.5 g/day). Following naltrexone removal, there was a 
slight, nonsignificant increase to 8.3---0.4 g/day. In the week 
following pump removal (control period, week 3), there was a 
small but significant decrease to 6.9---0.5 g/day. 
D I S C U S S I O N  
These data indicate that previous exposure to a self-selection 
paradigm alters feeding responses to naltrexone. In rats adapted 
to the diets prior to drug infusions, naltrexone reduced total in- 
take but did not change diet preferences. In rats given naltrex- 
one at the t ime diets were in t roduced,  a " p o l a r i z a t i o n "  
phenomenon was observed: rats tended to consume nearly all of 
their dally calories from either one diet or the other. These pref- 
erences generally became less extreme following drug with- 
drawal. Extreme preferences tot i~oth diets were o O , , c ~ c t  ~ h u i  
suggests that the effect of the drug was not diet @e~'J~ 
The primary goal of this experiment was lo determine me ~_I. 
feet of naltrexone on the development and maintenance oi diet 
preferences. This goal mandated that one group of rats be given 
naltrexone before baseline preferences for the diets could t'~ + es- 
tablished. It is possible that the extreme preferences observed 
were not caused by the drug, and would have been observed 
even if no manipulations had occurred. We consider this Oo,,si- 
bility unlikely for three reasons: 11 preferences this extreme did 
not occur as frequently in the group that received saline first+ 
2) the extreme preferences dissipated following nahrexone with- 
drawal, and 3) in previous work with these diets, we have not 
observed such a high frequency of extreme preterences~ 
A rat 's responsiveness to no~el stimuli ma> be an important 
factor in determining the initial response to novel diets as well 
as the eventual development of a preference or aversiom h ha,', 
been reported that naloxone and naltrexone reduce exploratory 
and/or locomotor activity elicited by exposure to a novel envi- 
ronment (I ,  13. 20, 22). Conversely, low doses o[ opioid ago- 
nists cause increases in exploratory and/or locomotor activity 
(4,5). A naltrexone-induced decrease in exploration might de- 
crease the likelihood that a novel diet is sampled enough to al- 
low development of a preference. In the present experiment, the 
extreme diet preferences of naltrexone-treated rats may be ', iewed 
as a failure to acquire a preference for one of the diets, given 
that saline-treated rats generally displayed a more equal prefer- 
ence for the diets. Similarly, Lynch (27) has shown that treat- 
ment with naloxone before daily I-h sessions with access to 
saccharin solution inhibited rats" acquisition of a preference lbr 
the solution. Daily treatment with a selective kappa opioid ago- 
nist, U-50,488H. facilitated the intake of a 20q sucrose solu- 
tion (28). 
If naltrexone diminished exploratory activity or responsive- 
ness to novel stimuli, it must be asked why the intakes of both 
diets were not decreased equally, since both were novel al the 
beginning of the experiment. Given that some rats (30%) became 
almost exclusive fat-preferrers, while others (60%) became al- 
most exclusive carbohydrate-preferrers, the extreme preferences 
do not appear to be due strictly to differences in sensory charac- 
teristics of the diets or in postabsorptive or metabolic conse- 
quences. The diet that an individual rat finds more " n o v e l "  may 
be related to a predisposition, possibly genetic, to consume fat. 
That genetics can influence fat preference is illustrated by the 
difference in self-selection of fat by obese and lean Zucker rats 
(7). Alternatively, the rats may have initially chosen a diet ran- 
domly. This diet, consumed out of caloric need, may ha\.e then 
acquired the status of being " 'non-novel ."  This diet would 
therefore become the preferred diet, as the naltrexone-treated rat 
would not be likely to explore for other novel foods. This hy- 
pothesis would require that rats form preferences soon after ini- 
tial exposure, as extreme preferences were observed within the 
first day of access to the diets. A fine-grained temporal analysis 
of the development of these preferences might shed additional 
light on the mechanism underlying the naltrexone effect  
Another consideration in the interpretation of the present re- 
sults is the possibility that naltrexone created a conditioned 
aversion to a particular diet in rats that were given naltrexone 
when the diets were first presented. Conditioned taste aversions 
have been produced in rats by naltrexone delivered orally, sub- 
cutaneously and intracerebroventricularly (36,371. In humans. 
nausea and malaise are sometimes reported after oral administra- 
tion of naltrexone (19, 29, 43). It is also known that preexpo- 
sure to a particular taste attenuates the subsequent conditioned 
aversion to that taste (l 1,40). This effect would explain why ex- 
treme diet preferences (or aversions) did not occur in ml~, ~hat 
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were familiar with the diets before naltrexone administration. It 
should be noted, however, that the aversive effects of naloxone, 
an antagonist pharmacologically similar to naltrexone, cannot 
completely account for its anorexic or antidipsogenic effects 
(14,24). In addition, it is not clear why an aversion would be 
limited to only one diet and why the avoided diet would not be 
the same for all rats. Both diets were novel when introduced. 
Based on the preferences of the group that received saline in- 
fusions first, rats generally display some preference, though not 
exclusive, for one diet over the other. It is possible that the 
stimulus properties of the less preferred diet were more readily 
associated with any illness or malaise that may have been caused 
by naltrexone. 
In addition to their ability to establish conditioned taste aver- 
sions, opioid antagonists have been shown to be effective un- 
conditioned stimuli for the establishment of conditioned place 
aversions (10,25). We do not believe such conditioning played a 
significant role in the present experiment because cage positions 
of the two diets were reversed daily. No consistent fluctuations 
in day-to-day preferences were apparent. 
In rats that were adapted to the diets before drug infusions 
began, naltrexone caused a decrease in the intakes of both diets. 
Although intake of the fat/protein diet returned to baseline sooner 
than did intake of the carbohydrate/protein diet, there were no 
significant changes from baseline in the percent of total calories 
consumed from each of the diets over the course of the naltrex- 
one infusion period. This lack of effect on diet preference may 
reflect the fact that these rats were not generally extreme in their 
preferences for the diets (30-75% fat preference at baseline). In 
a recently submitted abstract, we found that in rats with approx- 
imately equal intakes of the fat and carbohydrate diets, centrally 
administered naloxone caused approximately equal reductions in 
the intakes of both diets (15). Similarly, morphine caused in- 
creases in the intakes of the two diets in a pattern that roughly 
paralleled the preferences for these two diets measured prior to 
injection (16). 
Curiously, total caloric intake, fat intake, and preference for 
the fat diet significantly increased following termination of nal- 
trexone infusions. In rats given naltrexone at the beginning of 
the experiment, an increase in total intake was also observed af- 
ter removal of the naltrexone pumps. As discussed above, the 
abnormal preferences in this group precluded conventional com- 
parisons of mean intakes of the two diets. This rebound effect 
after termination of drug treatment is similar to that reported by 
Millan and Morris (34). With rats maintained on standard lab 
chow, they found increases in food and water intake and in body 
weight after termination of chronic SC naloxone infusions. In 
contrast, Marks-Kaufman and Kanarek (33) gave daily IP injec- 
tions of naloxone to rats allowed to self-select their diets while 
on a restricted feeding schedule. They found that fat intake was 
slightly reduced during the injection period and returned to con- 
trol levels in the postdrug period. Differences in the schedule of 
drug delivery, the feeding schedule and/or the type of diets used 
may explain the differences observed after the termination of 
drug administration. The increases observed in the present re- 
port and that of Millan and Morris (34) may be due to a super- 
sensitivity to endogenous opioids in brain systems which play a 
role in mediating food intake and/or palatability. It is known that 
chronic opioid antagonist treatment causes an up-regulation of 
opioid receptors and a supersensitivity to the effects of opioids 
(2, 35, 44, 45). It will be necessary, however, to test rats with 
differing baseline diet preferences to determine whether our 
postnaltrexone results represent a diet-selective effect of opioid 
receptor up-regulation. 
Decreases in body weight and/or weight gain have been re- 
ported for a number of opioid antagonists (3, 30, 32, 34). In the 
present study, naltrexone caused a significant reduction in daily 
rate of weight gain in rats that received naltrexone after adap- 
tation to the diets. Interestingly, in rats that received naltrex- 
one at the beginning of the experiment, daily rate of weight gain 
was similar to that of saline-infused rats, even though there was 
an initial decrease in weight. Although food intake appeared to 
be depressed to a degree similar to that in the group that re- 
ceived naltrexone after adaptation to the diets, the aforemen- 
tioned feeding irregularities of the NTX-Saline-Ctl group make 
this finding difficult to interpret at present. 
In summary, we have observed that adaptation to a dietary 
self-selection regime alters the effects of continuous infusion of 
an opioid antagonist. In rats adapted to the regime, naltrexone 
caused a decrease in the intakes of fat/protein and carbohydrate/ 
protein diets. Relative preferences for the two diets were gener- 
ally unchanged. In contrast, when naltrexone was infused at the 
time of introduction of the diets, a polarization phenomenon was 
observed: rats exhibited extreme preferences for one of the di- 
ets. Because these preferences were not directed toward the same 
diet in all rats, the effect does not appear to be diet- or macro- 
nutrient-specific. Naltrexone-induced reductions in exploratory 
behavior may partially explain this effect. These results empha- 
size the importance of examining individual differences as well 
as baseline preferences in studies on the control of intake and 
diet selection. 
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